A targeted genetic test for detecting Alzheimer's disease risk genes, particularly APOE variants. This test assesses genetic predisposition to Alzheimer's disease for early intervention planning.
Manufactured by
Shenzhen HaploX Biotechnology Co., Ltd.
China
HaploX Biotechnology specializes in tumor liquid biopsy and genetic big data technologies. The company operates CAP/CLIA/EMQN/NCCL certified medical laboratories equipped with advanced gene sequencing platforms. Services cover tumor management, hereditary disease screening, and infectious disease detection, serving hundreds of hospitals and research institutions across China with international operations in Hong Kong, Singapore, Japan, Europe, and North America.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Cygnus Biosciences (Beijing)Co., Ltd.
China · 4 relevant products
BioChain (Beijing) Science & Technology. Inc.
China · 2 relevant products
ADmit Therapeutics SL
Spain · 2 relevant products
54 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →15 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 35 relevant matches
Cygnus Biosciences (Beijing)Co., Ltd. · China
This product detects familial Alzheimer's disease risk genes to help predict family-onset Alzheimer's disease risk in individuals, identify high-risk populations, and enable early prevention and intervention measures.
National Reference Laboratory · United Arab Emirates
Advanced Alzheimer's blood testing utilizing precision biomarker testing for early detection and prevention of Alzheimer's disease and other dementias. This is the first of its kind in the UAE and MENA region, providing precision biomarker testing to protect brain health.
National Reference Laboratory · United Arab Emirates
Precision biomarker testing for early detection and monitoring of Alzheimer's disease and other dementias. This specialized service enables early intervention and prevention strategies for neurodegenerative conditions.
32 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products